Participating Faculty

Supplements and Featured Publications, The Next Era of Anticoagulation Therapy, Volume 10, Issue 3 Suppl

The American Journal of Managed Care

This supplement to contains information on anticoagulation therapy for the treatment of atrial fibrillation.

Chairs

Charles S. Abrams, MD

Division of Hematology-Oncology

Philadelphia, Pennsylvania

Geno J. Merli, MD

Vice Chairman for Clinical Affairs

Senior Associate Dean for Continuing Medical Education

Thomas Jefferson University Hospital

Faculty

Khalid Abusaada, MD

Drexel University School of Medicine

Assistant Professor

Duke Center for Cerebrovascular Disease

Center for Clinical Health Policy Research

Durham, North Carolina

Michael D. Ezekowitz, MD, PhD

Cardiovascular Medicine Department

Philadelphia, Pennsylvania

Alan S. Go, MD

Division of Research

Oakland, California

Radhika Jaladi, MD

Drexel University School of Medicine

Professor of Medicine and Director

Duke University Medical Center

Durham VA Medical Center

Research Fellow

McMaster University

Canada

Sushant B. Sharma, MD

Drexel University School of Medicine

Professor of Medicine and Biochemistry

Canada Research Chair (Tier 1) in Thrombosis

J.F. Mustard Chair in Cardiovascular Research

Hamilton, Ontario

FACULTY DISCLOSURE

It is policy at the University of Pennsylvania School of Medicine for faculty participating in continuing medical education activities to disclose to participants any significant financial interest or other relationship(s) maintained with a commercial company that has provided financial support for the activity, or whose products or services may be related to the subject matter of the educational content.

The intent of this disclosure is to allow participants to form their own judgments about the educational content of this activity with a full disclosure of the facts. It remains for participants to determine whether a faculty member's interest or relationships may have influenced the presentation in either the exposition or the conclusions presented.

The American Journal of Managed Care

It is policy at to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest.

The following faculty have reported receiving something of value* from the commercial supporter(s) of this activity or from a corporate organization whose product(s) may have relevance to the content of their presentations:

Charles S. Abrams, MD

  • Consultant To: Berlex Laboratories GlaxoSmithKline

  • Michael D. Ezekowitz, MD, PhD Consultant To/ Grant/Research Support From: AstraZeneca

  • David B. Matchar, MD Speaker's Bureau For: AstraZeneca
  • Bayer Bristol-Myers Squibb

  • Speaker's Bureau For: AstraZeneca Aventis

  • Jeffrey I. Weitz, MD Consultant To/Received Honoraria From: AstraZeneca

The following faculty have reported no commercial support:

  • Alan S. Go, MD
  • Cheryl D. Bushnell, MD, MHS
  • Sushant B. Sharma, MD

Investigational and/or Off-Label Use of Commercial Products and Devices

The University of Pennsylvania School of Medicine requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

The following information was provided by the faculty:

Faculty:Geno J. Merli, MD

Investigational and/or off-label use:Not yet approved by the FDA

Faculty:Geno J. Merli, MD

Investigational and/or off-label use:Not yet approved by the FDA

*Something of value refers to any equity position, receipt of royalties/honoraria, funding of a research grant, consultations, or to any other relationship with a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policies.